EFFICACY AND SAFETY OF LOMUSTINE VERSUS FOTEMUSTINE AS FIRST AND SECOND LINE TREAMENT IN RELAPSED GLIOBLASTOMA PATIENTS

被引:0
|
作者
Domenech, M. [1 ]
Fabregat, C. [2 ]
Hernandez, A. [1 ]
del Barco, S. [3 ]
Panciroli, C. [1 ]
Garcia-Illescas, D. [4 ,5 ]
Vieito, M. [4 ,5 ]
Vilarino, N. [2 ]
Mesia, C. [2 ]
Balana, C. [1 ]
机构
[1] Catalan Inst Oncol Badalona, Badalona, Spain
[2] Catalan Inst Oncol Hosp, Lhospitalet De Llobregat, Spain
[3] Hosp Josep Trueta, Catalan Inst Oncol Girona, Girona, Spain
[4] Vall dHebron Univ Hosp, Barcelona, Spain
[5] Inst Oncol VHIO, Barcelona, Spain
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P14.58
引用
收藏
页码:49 / 49
页数:1
相关论文
共 50 条
  • [1] Efficacy and safety of second-line fotemustine in elderly patients with recurrent glioblastoma
    Santoni, Matteo
    Scoccianti, Silvia
    Lolli, Ivan
    Fabrini, Maria Grazia
    Silvano, Giovanni
    Detti, Beatrice
    Perrone, Franco
    Savio, Giuseppina
    Iacovelli, Roberto
    Burattini, Luciano
    Berardi, Rossana
    Cascinu, Stefano
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2013, 113 (03) : 397 - 401
  • [2] Efficacy and safety of second-line fotemustine in elderly patients with recurrent glioblastoma
    Matteo Santoni
    Silvia Scoccianti
    Ivan Lolli
    Maria Grazia Fabrini
    Giovanni Silvano
    Beatrice Detti
    Franco Perrone
    Giuseppina Savio
    Roberto Iacovelli
    Luciano Burattini
    Rossana Berardi
    Stefano Cascinu
    [J]. Journal of Neuro-Oncology, 2013, 113 : 397 - 401
  • [3] Efficacy and safety of fotemustine for the treatment of relapsed and refractory multiple myeloma patients
    Mangiacavalli, Silvia
    Pica, GianMatteo
    Varettoni, Marzia
    Lazzarino, Mario
    Corso, Alessandro
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2009, 82 (03) : 240 - 241
  • [4] Efficacy and safety study of fotemustine and bevacizumab in patients with recurrent glioblastoma.
    Escudero, Laura Sanchez
    Urbano, Maria Amor
    Garces, Maria Yeray Rodriguez
    Murillo, Fatima Toscano
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [5] Second line chemotherapy with fotemustine (FTMS) for the treatment of patients (Pts) with glioblastoma multiforme
    Paccapelo, A.
    Ricciuti, R.
    Cardinali, M.
    Trignani, R.
    Burattini, L.
    Fabbietti, L.
    Pezzoli, M.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : 68 - 68
  • [6] Second-line treatment of bevacizumab plus lomustine versus bevacizumab plus irinotecan in patients with recurrent glioblastoma
    Simoes, J.
    Tavares, N. T.
    Borges, C.
    Meireles, S.
    Fernandes, C.
    Costa, A.
    Caeiro, C.
    Damasceno, M.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [7] Toxicity and efficacy of lomustine and bevacizumab in recurrent glioblastoma patients
    Jakobsen, J. N.
    Urup, T.
    Grunnet, K.
    Toft, A.
    Johansen, M. D.
    Poulsen, S. H.
    Christensen, I. J.
    Muhic, A.
    Poulsen, H. S.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2018, 137 (02) : 439 - 446
  • [8] Toxicity and efficacy of lomustine and bevacizumab in recurrent glioblastoma patients
    J. N. Jakobsen
    T. Urup
    K. Grunnet
    A. Toft
    M. D. Johansen
    S. H. Poulsen
    I. J. Christensen
    A. Muhic
    H. S. Poulsen
    [J]. Journal of Neuro-Oncology, 2018, 137 : 439 - 446
  • [9] EORTC 26101 PHASE III TRIAL EXPLORING THE COMBINATION OF BEVACIZUMAB AND LOMUSTINE VERSUS LOMUSTINE IN PATIENTS WITH FIRST PROGRESSION OF A GLIOBLASTOMA
    van den Bent, M.
    Gorlia, T.
    Bendszus, M.
    Sahm, F.
    Domont, J.
    Idbaih, A.
    Platten, M.
    Weller, M.
    Golfoinopoulos, V.
    Wick, W.
    [J]. NEURO-ONCOLOGY, 2016, 18 : 1 - 2
  • [10] Phase III Randomized Trial Comparing the Efficacy of Cediranib As Monotherapy, and in Combination With Lomustine, Versus Lomustine Alone in Patients With Recurrent Glioblastoma
    Batchelor, Tracy T.
    Mulholland, Paul
    Neyns, Bart
    Nabors, L. Burt
    Campone, Mario
    Wick, Antje
    Mason, Warren
    Mikkelsen, Tom
    Phuphanich, Surasak
    Ashby, Lynn S.
    DeGroot, John
    Gattamaneni, Rao
    Cher, Lawrence
    Rosenthal, Mark
    Payer, Franz
    Juergensmeier, Juliane M.
    Jain, Rakesh K.
    Sorensen, A. Gregory
    Xu, John
    Liu, Qi
    van den Bent, Martin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (26) : 3212 - 3218